Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Induction Chemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 10 Leukemia, Myeloid, Acute 4 Nasopharyngeal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Turcot syndrome 1 Tongue Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Locally Advanced Malignant Neoplasm 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophagitis 1 Esophageal Neoplasms 1

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011060 2017-01-10

NACVCAC

The First Hospital of Jilin University

Phase 3 Unknown

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡